05/23/23 11:17 PMNasdaq : CAMX fda approvalCamurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorderCamurus today announces that the US Food and Drug Administration has approved Brixadi™ extended release injection for subcutaneous use, a weekly and monthly...RHEA-AIneutral
02/15/23 9:00 AMNYSE : CAMX Cambiar Investors Launches Aggressive Value ETFCambiar Investors, a leading global relative value manager, today announced the launch of the Cambiar Aggressive Value ETF, a new actively managed exchange-traded fund providing investors with exposure to a concentrated, best ideas strategy in a streamlined and efficient wrapper. Created from the conversion of the Cambiar Aggressive Value Fund, CAMX...RHEA-AIvery positive
